Cytek Biosciences Inc (NQ: CTKB )
8.070 -0.120 (-1.47%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Headline News about Cytek Biosciences Inc
Where Cytek Biosciences Stands With Analysts
May 10, 2023
Recap: Cytek Biosciences Q1 Earnings
May 09, 2023
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 26, 2023
Cytek Biosciences Earnings Perspective: Return On Capital Employed
December 15, 2022
Piper Sandler Maintains Overweight Rating for Cytek Biosciences: Here's What You Need To Know
August 18, 2022
Piper Sandler has decided to maintain its Overweight rating of Cytek Biosciences (NASDAQ:CTKB) and raise its price target from $12.00 to $16.00. Shares of Cytek Biosciences are trading down 0.21%...
74 Biggest Movers From Yesterday
June 03, 2022
Goldman Sachs has decided to maintain its Buy rating of Cytek Biosciences (NASDAQ:CTKB) and lower its price target from $14.00 to $12.00. Shares of Cytek Biosciences are trading up 10.93% over the last...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following